41 – 50 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Proteoglycans : a common portal for SARS-CoV-2 and extracellular vesicle uptake
- Contribution to journal › Scientific review
-
Mark
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2
- Contribution to journal › Article
-
Mark
Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care : a matched cohort study
- Contribution to journal › Article
-
Mark
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses
- Contribution to journal › Article
-
Mark
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
- Contribution to journal › Article
-
Mark
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
- Contribution to journal › Article
-
Mark
Inhaled ciclesonide in adults hospitalised with COVID-19 : a randomised controlled open-label trial (HALT COVID-19)
- Contribution to journal › Article
- 2022
-
Mark
Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women
- Contribution to journal › Article
-
Mark
Diffuse alveolar damage patterns reflect the immunological and molecular heterogeneity in fatal COVID-19
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
- Contribution to journal › Article
